Postexercise serum from humans influences the biological tug of war of APP processing in human neuronal cells

• Published in: American Journal of Physiology: Cell Physiology Vol. 322; no. 4; p. C614
• Main Authors: Marko, Daniel M, Finch, Michael S, Mohammad, Ahmad, MacNeil, Adam J, Klentrou, Panagiota, MacPherson, Rebecca E K
• Format: Journal Article
• Language: English
• Published: United States 01-04-2022
• Subjects: Alzheimer Disease - genetics; Amyloid beta-Peptides; Amyloid beta-Protein Precursor - genetics; Amyloid beta-Protein Precursor - metabolism; Amyloid Precursor Protein Secretases - genetics; Amyloid Precursor Protein Secretases - metabolism; Aspartic Acid Endopeptidases - genetics; Aspartic Acid Endopeptidases - metabolism; Humans; BACE1; ADAM10; exercise; neurons
• ISSN: 1522-1563
• DOI: 10.1152/ajpcell.00418.2021

Neurodegenerative diseases such as Alzheimer's disease (AD) are becoming more prevalent in our aging society. One specific neuropathological hallmark of this disease is the accumulation of amyloid-β (Aβ) peptides, which aggregate to form extraneuronal plaques. Increased Aβ peptides are often observed well before symptoms of AD develop, highlighting the importance of targeting Aβ-producing pathways early on in disease progression. Evidence indicates that exercise has the capacity to reduce Aβ peptide production in the brain; however, the mechanisms remain unknown. Exercise-induced signaling mediators could be the driving force behind some of the beneficial effects observed in the brain with exercise. The purpose of this study was to examine if postexercise serum and the factors it contains can alter neuronal amyloid precursor protein (APP) processing. Human SH-SY5Y neuronal cells were differentiated with retinoic acid for 5 days and treated with 10% pre- or postexercise serum from humans for 30 min. Cells were collected for analysis of acute (30 min;
= 6) or adaptive (24 h posttreatment;
= 6) responses. There were no statistical differences in a disintegrin and metalloproteinase 10 (ADAM10) and β-site amyloid precursor protein cleaving enzyme 1 (BACE1) mRNA or protein expression with postexercise serum treatment at either time point. However, there was an increase in the ratio of soluble amyloid precursor protein α (sAPPα) to soluble amyloid precursor protein β (sAPPβ) protein content (
= 0.05) after 30 min of postexercise serum treatment. In addition, 30 min of postexercise serum treatment increased ADAM10 (
= 0.01) and BACE1 (
= 0.02) activity. These findings suggest that postexercise serum modulates important enzymes involved in APP processing, potentially pushing the cascade toward the nonamyloidogenic arm.